drugset
drugset / Trial / NCT02760342

A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and Metformin

NCT02760342 ↗

Phase 1 Completed 24 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelBasic science

Summary

The objective of this study is to evaluate the pharmacokinetic interactions between ASP015K and metformin in healthy non-elderly male subjects.

Timeline

Start
2016-05-15
Primary completion
2016-06-26
Completion
2016-06-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — Oral
Subject peficitinib Small molecule — Oral

Indications

No indication recorded.